0001411690-22-000016.txt : 20220711 0001411690-22-000016.hdr.sgml : 20220711 20220711165112 ACCESSION NUMBER: 0001411690-22-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220707 FILED AS OF DATE: 20220711 DATE AS OF CHANGE: 20220711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARKER DAVID L CENTRAL INDEX KEY: 0001189124 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38613 FILM NUMBER: 221077394 MAIL ADDRESS: STREET 1: 9885 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bionano Genomics, Inc. CENTRAL INDEX KEY: 0001411690 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 261756290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9540 TOWNE CENTRE DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 888-7600 MAIL ADDRESS: STREET 1: 9540 TOWNE CENTRE DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Bionano Genomics, Inc DATE OF NAME CHANGE: 20190308 FORMER COMPANY: FORMER CONFORMED NAME: BioNano Genomics, Inc DATE OF NAME CHANGE: 20120703 FORMER COMPANY: FORMER CONFORMED NAME: BioNanomatrix Inc DATE OF NAME CHANGE: 20070906 4 1 wf-form4_165757265259092.xml FORM 4 X0306 4 2022-07-07 0 0001411690 Bionano Genomics, Inc. BNGO 0001189124 BARKER DAVID L C/O BIONANO GENOMICS, INC. 9540 TOWNE CENTRE DRIVE, SUITE 100 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2022-07-07 4 M 0 44470 0.51 A 58364 D Stock Option (Right to Buy) 0.51 2022-07-07 4 M 0 44470 0 D 2030-06-30 Common Stock 44470.0 0 D The shares vested in equal monthly installments over a one year period such that the option became fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan). The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029. /s/ R. Erik Holmlin, Attorney-in-Fact 2022-07-11